Nancy L. Rolli

FDA investigator

Appears on 4 documents from 2005 to 2015, mostly at sites in New Jersey. Most often cites production record review (21 CFR 211.192).

4
Documents on file
8.3
Observations per 483
2005
First seen
2015
Most recent

What they cite most

From 25 observations

Activity by year

2005: 2, 2006: 1, 2015: 1

Where

New Jersey 4

Is Nancy L. Rolli coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

4 documents, newest first
FirmOpen
Amended 483 Able Laboratories, Inc.Jul 24, 2015 · Cranbury, New Jersey
EIR Actavis Totowa LLCAug 10, 2006 · Little Falls, New Jersey
Amended 483 Able Laboratories, Inc.Jul 6, 2005 · Cranbury, New Jersey
483 Able Laboratories, IncJul 1, 2005 · Cranbury, New Jersey

About this profile

What does Nancy L. Rolli inspect?

Nancy L. Rolli appears on 4 documents on file covering 2 sites, mostly in New Jersey.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.22 and 21 CFR 314.81.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Nancy L. Rolli is dated Jul 24, 2015.

FDA Investigator Nancy L. Rolli: 483s & Inspections · FDA Intel